Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 2
2006 5
2007 2
2008 6
2009 3
2010 2
2011 4
2012 6
2013 4
2014 4
2015 6
2016 1
2017 2
2018 5
2019 8
2020 6
2021 5
2022 6
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib for the treatment of psoriasis and psoriatic arthritis.
Berekmeri A, Mahmood F, Wittmann M, Helliwell P. Berekmeri A, et al. Among authors: wittmann m. Expert Rev Clin Immunol. 2018 Sep;14(9):719-730. doi: 10.1080/1744666X.2018.1512404. Expert Rev Clin Immunol. 2018. PMID: 30118353 Free article. Review.
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases.
Bridgewood C, Wittmann M, Macleod T, Watad A, Newton D, Bhan K, Amital H, Damiani G, Giryes S, Bragazzi NL, McGonagle D. Bridgewood C, et al. Among authors: wittmann m. J Invest Dermatol. 2022 Oct;142(10):2660-2667. doi: 10.1016/j.jid.2022.03.013. Epub 2022 Apr 6. J Invest Dermatol. 2022. PMID: 35395222 Free article.
Hand eczema leaves systemic traces.
Roesner LM, Wittmann M. Roesner LM, et al. Among authors: wittmann m. Br J Dermatol. 2023 Aug 24;189(3):e56-e59. doi: 10.1093/bjd/ljad178. Br J Dermatol. 2023. PMID: 37226228 No abstract available.
Molecular and cellular regulation of psoriatic inflammation.
Macleod T, Bridgewood C, Hyde I, Heague M, Helliwell P, Stacey M, Wittmann M. Macleod T, et al. Among authors: wittmann m. Clin Sci (Lond). 2022 Jun 30;136(12):935-952. doi: 10.1042/CS20210916. Clin Sci (Lond). 2022. PMID: 35730381 Review.
Cytokines as therapeutic targets in skin inflammation.
Wittmann M, McGonagle D, Werfel T. Wittmann M, et al. Cytokine Growth Factor Rev. 2014 Aug;25(4):443-51. doi: 10.1016/j.cytogfr.2014.07.008. Epub 2014 Aug 1. Cytokine Growth Factor Rev. 2014. PMID: 25164568 Review.
IL-18 and skin inflammation.
Wittmann M, Macdonald A, Renne J. Wittmann M, et al. Autoimmun Rev. 2009 Sep;9(1):45-8. doi: 10.1016/j.autrev.2009.03.003. Epub 2009 Mar 11. Autoimmun Rev. 2009. PMID: 19285156 Review.
The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier.
Macleod T, Berekmeri A, Bridgewood C, Stacey M, McGonagle D, Wittmann M. Macleod T, et al. Among authors: wittmann m. Front Immunol. 2021 Dec 23;12:808012. doi: 10.3389/fimmu.2021.808012. eCollection 2021. Front Immunol. 2021. PMID: 35003136 Free PMC article. Review.
Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis.
Savage LJ, Wittmann M, McGonagle D, Helliwell PS. Savage LJ, et al. Among authors: wittmann m. Rheumatol Ther. 2015 Jun;2(1):1-16. doi: 10.1007/s40744-015-0010-2. Epub 2015 Mar 17. Rheumatol Ther. 2015. PMID: 27747495 Free PMC article. Review.
81 results